Insider filing · MRK

Douglas M Baker Jr bought $1.3M of Merck & (MRK)

Executed Feb 5 2025, disclosed Feb 7 2025, 2 days later.

Over the 21 trading sessions from the disclosed entry session (Feb 7 2025), the stock returned +8.8% (delay-adjusted); from the execution session (Feb 5 2025), +4.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

DJ Douglas M Baker Jr Director profile →

Douglas M Baker Jr (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Merck & Co., Inc. (MRK). Across 1 priced purchase filing, the average 21-session return was +4.0% from execution and +8.8% from disclosure (delay-adjusted; derived). The largest single filing was $1.3M of MRK (15,000 sh × $88.50, as filed), executed Feb 5 2025.

MRK Merck & Co., Inc. MRK · Healthcare · 67 filings in 24 months ticker →

Healthcare · Merck & Co., Inc. operates as a healthcare company worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→